Identifying Drug Targets in Pancreatic Ductal Adenocarcinoma Through Machine Learning, Analyzing Biomolecular Networks, and Structural Modeling

Pancreatic ductal adenocarcinoma (PDAC) is one of the leading causes of cancer-related death and has an extremely poor prognosis. Thus, identifying new disease-associated genes and targets for PDAC diagnosis and therapy is urgently needed. This requires investigations into the underlying molecular m...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Wenying, Liu, Xingyi, Wang, Yibo, Han, Shuqing, Wang, Fan, Liu, Xin, Xiao, Fei, Hu, Guang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204992/
https://www.ncbi.nlm.nih.gov/pubmed/32425783
http://dx.doi.org/10.3389/fphar.2020.00534

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204992/
https://www.ncbi.nlm.nih.gov/pubmed/32425783
http://dx.doi.org/10.3389/fphar.2020.00534

Ejemplares similares